R. Motl, E. Sebastião, R. Klaren, E. McAuley, E. Stine-Morrow, B. Roberts
{"title":"体育活动与多发性硬化症健康衰老——文献综述及研究方向","authors":"R. Motl, E. Sebastião, R. Klaren, E. McAuley, E. Stine-Morrow, B. Roberts","doi":"10.17925/USN.2016.12.01.29","DOIUrl":null,"url":null,"abstract":"TOUCH MEDICAL MEDIA 29 Of the 400,000 adults living with multiple sclerosis (MS) in the US, an estimated 30% are between the age of 55–64 years and nearly 15% are 65 years of age or older.1 There is additional evidence of a shift in the peak prevalence of MS among older age groups. For example, the peak prevalence of MS in Manitoba, Canada occurred at 35–39 years of age, with no documented cases beyond an age of 64 years, in 1984.2 By 2004, the peak prevalence was at 55–59 years of age, with cases of MS documented beyond 80 years of age.2 This represents a “greying” of the MS population that coincides with both increased survival of those with MS and the shifting demographic landscape worldwide.3 That is, there are greater numbers of older adults living with MS than ever before, and this trend will continue over the foreseeable decades. This will present both clinical and public health problems for managing the consequences of aging with MS as a chronic condition.","PeriodicalId":90076,"journal":{"name":"US neurology","volume":"12 1","pages":"29-33"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"15","resultStr":"{\"title\":\"Physical activity and healthy aging with multiple sclerosis-Literature review and research directions\",\"authors\":\"R. Motl, E. Sebastião, R. Klaren, E. McAuley, E. Stine-Morrow, B. Roberts\",\"doi\":\"10.17925/USN.2016.12.01.29\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"TOUCH MEDICAL MEDIA 29 Of the 400,000 adults living with multiple sclerosis (MS) in the US, an estimated 30% are between the age of 55–64 years and nearly 15% are 65 years of age or older.1 There is additional evidence of a shift in the peak prevalence of MS among older age groups. For example, the peak prevalence of MS in Manitoba, Canada occurred at 35–39 years of age, with no documented cases beyond an age of 64 years, in 1984.2 By 2004, the peak prevalence was at 55–59 years of age, with cases of MS documented beyond 80 years of age.2 This represents a “greying” of the MS population that coincides with both increased survival of those with MS and the shifting demographic landscape worldwide.3 That is, there are greater numbers of older adults living with MS than ever before, and this trend will continue over the foreseeable decades. This will present both clinical and public health problems for managing the consequences of aging with MS as a chronic condition.\",\"PeriodicalId\":90076,\"journal\":{\"name\":\"US neurology\",\"volume\":\"12 1\",\"pages\":\"29-33\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"15\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"US neurology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17925/USN.2016.12.01.29\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"US neurology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17925/USN.2016.12.01.29","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Physical activity and healthy aging with multiple sclerosis-Literature review and research directions
TOUCH MEDICAL MEDIA 29 Of the 400,000 adults living with multiple sclerosis (MS) in the US, an estimated 30% are between the age of 55–64 years and nearly 15% are 65 years of age or older.1 There is additional evidence of a shift in the peak prevalence of MS among older age groups. For example, the peak prevalence of MS in Manitoba, Canada occurred at 35–39 years of age, with no documented cases beyond an age of 64 years, in 1984.2 By 2004, the peak prevalence was at 55–59 years of age, with cases of MS documented beyond 80 years of age.2 This represents a “greying” of the MS population that coincides with both increased survival of those with MS and the shifting demographic landscape worldwide.3 That is, there are greater numbers of older adults living with MS than ever before, and this trend will continue over the foreseeable decades. This will present both clinical and public health problems for managing the consequences of aging with MS as a chronic condition.